메뉴 건너뛰기




Volumn 41, Issue 4, 2010, Pages 581-587

Racial disparities in awareness and treatment of atrial fibrillation: The REasons for geographic and racial differences in stroke (REGARDS) study

Author keywords

Atrial fibrillation; Racial disparities; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

EID: 77950208123     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.573907     Document Type: Article
Times cited : (126)

References (17)
  • 1
    • 0035832261 scopus 로고    scopus 로고
    • Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagu-lation and risk factors in atrial fibrillation (ATRIA) study
    • Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: the anticoagu-lation and risk factors in atrial fibrillation (ATRIA) study. JAMA. 2001; 285:2370-2375.
    • (2001) JAMA , vol.285 , pp. 2370-2375
    • Go, A.S.1    Hylek, E.M.2    Phillips, K.A.3    Chang, Y.4    Henault, L.E.5    Selby, J.V.6    Singer, D.E.7
  • 2
    • 34347394385 scopus 로고    scopus 로고
    • Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    • Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-867.
    • (2007) Ann Intern Med , vol.146 , pp. 857-867
    • Hart, R.G.1    Pearce, L.A.2    Aguilar, M.I.3
  • 3
    • 0344861847 scopus 로고    scopus 로고
    • Anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials translate into clinical practice?
    • Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM, Jensvold NG, Selby JV, Singer DE. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA. 2003;290:2685-2692.
    • (2003) JAMA , vol.290 , pp. 2685-2692
    • Go, A.S.1    Hylek, E.M.2    Chang, Y.3    Phillips, K.A.4    Henault, L.E.5    Capra, A.M.6    Jensvold, N.G.7    Selby, J.V.8    Singer, D.E.9
  • 4
    • 0007939368 scopus 로고    scopus 로고
    • Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness
    • Kalra L, Yu G, Perez I, Lakhani A, Donaldson N. Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness. BMJ. 2000;320:1236-1239.
    • (2000) BMJ , vol.320 , pp. 1236-1239
    • Kalra, L.1    Yu, G.2    Perez, I.3    Lakhani, A.4    Donaldson, N.5
  • 5
    • 0033593072 scopus 로고    scopus 로고
    • Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study
    • Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med. 1999;131:927-934.
    • (1999) Ann Intern Med , vol.131 , pp. 927-934
    • Go, A.S.1    Hylek, E.M.2    Borowsky, L.H.3    Phillips, K.A.4    Selby, J.V.5    Singer, D.E.6
  • 6
    • 27144528554 scopus 로고    scopus 로고
    • Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system
    • Darkow T, Vanderplas AM, Lew KH, Kim J, Hauch O. Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system. Curr Med Res Opin. 2005;21: 1583-1594.
    • (2005) Curr Med Res Opin , vol.21 , pp. 1583-1594
    • Darkow, T.1    Vanderplas, A.M.2    Lew, K.H.3    Kim, J.4    Hauch, O.5
  • 7
    • 33744781804 scopus 로고    scopus 로고
    • Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: Effects of an educational intervention programme. the West Birmingham Atrial Fibrillation Project
    • Lane DA, Ponsford J, Shelley A, Sirpal A, Lip GY. Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme. The West Birmingham Atrial Fibrillation Project. Int J Cardiol. 2006;110:354-358.
    • (2006) Int J Cardiol , vol.110 , pp. 354-358
    • Lane, D.A.1    Ponsford, J.2    Shelley, A.3    Sirpal, A.4    Lip, G.Y.5
  • 9
    • 0035854054 scopus 로고    scopus 로고
    • Validation of clinical classification schemes for predicting stroke: Results from the national registry of atrial fibrillation
    • Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the national registry of atrial fibrillation. JAMA. 2001;285: 2864-2870.
    • (2001) JAMA , vol.285 , pp. 2864-2870
    • Gage, B.F.1    Waterman, A.D.2    Shannon, W.3    Boechler, M.4    Rich, M.W.5    Radford, M.J.6
  • 11
    • 0034798408 scopus 로고    scopus 로고
    • Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination
    • Jones WJ, Williams LS, Meschia JF. Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination. Stroke. 2001;32:2232-2236.
    • (2001) Stroke , vol.32 , pp. 2232-2236
    • Jones, W.J.1    Williams, L.S.2    Meschia, J.F.3
  • 13
    • 33748642599 scopus 로고    scopus 로고
    • American College of Cardiology, American Heart Association Task Force, European Society of Cardiology Committee for Practice Guidelines.
    • Association EHR, Heart Rhythm Society ZD, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, American College of Cardiology, American Heart Association Task Force, European Society of Cardiology Committee for Practice Guidelines. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006; 48:e247-e346.
    • (2006) J Am Coll Cardiol , vol.48
  • 14
    • 45949095568 scopus 로고    scopus 로고
    • Antithrombotic therapy in atrial fibrillation
    • American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
    • Singer D, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip G, Manning WJ. Antithrombotic therapy in atrial fibrillation. American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:546S-592S.
    • (2008) Chest , vol.133
    • Singer, D.1    Albers, G.W.2    Dalen, J.E.3    Fang, M.C.4    Go, A.S.5    Halperin, J.L.6    Lip, G.7    Manning, W.J.8
  • 15
    • 0038804145 scopus 로고    scopus 로고
    • Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care
    • Williams D, Bennett K, Feely J. Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care. Br J Clin Pharmacol. 2003;55:604-608.
    • (2003) Br J Clin Pharmacol , vol.55 , pp. 604-608
    • Williams, D.1    Bennett, K.2    Feely, J.3
  • 16
    • 41949097069 scopus 로고    scopus 로고
    • Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins
    • Enriquez JR, Pratap P, Zbilut JP, Calvin JE, Volgman AS. Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins. Gend Med. 2008;5:53-61.
    • (2008) Gend Med , vol.5 , pp. 53-61
    • Enriquez, J.R.1    Pratap, P.2    Zbilut, J.P.3    Calvin, J.E.4    Volgman, A.S.5
  • 17
    • 33750309511 scopus 로고    scopus 로고
    • Relationship between quality of care and racial disparities in Medicare health plans
    • Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ. Relationship between quality of care and racial disparities in Medicare health plans. JAMA. 2006;296:1998-2004.
    • (2006) JAMA , vol.296 , pp. 1998-2004
    • Trivedi, A.N.1    Zaslavsky, A.M.2    Schneider, E.C.3    Ayanian, J.Z.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.